Webinar series

Improving academia-industry

collaborative trials

Why does data quality and traceability matter? Are you getting what you pay for? What resources are required for running a Fit For Filing trial? 

Academic trials are not usually part of the marketing authorisation process of a new drug. But why is that? Let’s explore how we can open up this opportunity to enable academia-industry collaborative trials to deliver data that can be used for licensing purposes (fit for filing).

What can you expect from this webinar series?

Should and could my trial be fit for filing

15 Sept

6-7:30pm CEST - 12-13:30pm EST

Academic trials are not usually part of the marketing authorisation process of a new drug. But why is that? Let’s explore how we can open up this opportunity to enable collaborative trials to deliver data that are fit for filing.

A spoonful of data helps the medicine go down: Purposeful collection of clean and reproducible trial data

20 Oct

6-7:30pm CEST - 12-13:30pm EST

Early collaboration and communication between all stakeholders is crucial to develop better trial protocols and to collect adequate data and documentation for a marketing authorisation application for a new drug.

With great trial needs come great responsibilities: Delivering high quality data and successfully file an application

10 Nov

6-7:30pm CEST - 12-13:30pm EST

Why does data quality and traceability matter? Are you getting what you pay for? What resources are required for running a Fit For Filing trial? Let’s explore data management, oversight, and the consequent resource considerations for fit for filing trials to improve the collaborative model and reach the common goal of filing an application.